Improving the Efficacy of Liver Cancer Immunotherapy: The Power of Combined Preclinical and Clinical Studies.

Feng, Gen-Sheng; Hanley, Kaisa L; Liang, Yan; Lin, Xiaoxue

Feng, Gen-Sheng; Hanley, Kaisa L; Liang, Yan; Lin, Xiaoxue.

Afiliação

Feng GS; Department of Pathology, School of Medicine; Molecular Biology Section, Division of Biological Sciences; and Moores Cancer Center, University of California at San Diego, La Jolla, CA.
Hanley KL; Department of Pathology, School of Medicine; Molecular Biology Section, Division of Biological Sciences; and Moores Cancer Center, University of California at San Diego, La Jolla, CA.
Liang Y; Department of Pathology, School of Medicine; Molecular Biology Section, Division of Biological Sciences; and Moores Cancer Center, University of California at San Diego, La Jolla, CA.
Lin X; Department of Pathology, School of Medicine; Molecular Biology Section, Division of Biological Sciences; and Moores Cancer Center, University of California at San Diego, La Jolla, CA.

Hepatology ; 73 Suppl 1: 104-114, 2021 01.

Article em En | MEDLINE | ID: mdl-32715491

Assuntos

Carcinoma Hepatocelular/tratamento farmacológico; Inibidores de Checkpoint Imunológico/uso terapêutico; Neoplasias Hepáticas/tratamento farmacológico; Animais; Neoplasias do Sistema Biliar/tratamento farmacológico; Humanos; Imunoterapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Inibidores de Checkpoint Imunológico / Neoplasias Hepáticas Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google